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INTRODUCTION
Celiac disease (CD) is an autoimmune enteropa-
thy triggered by the ingestion of gluten in genetically 
susceptible individuals(2). Once thought to be a rare 
disease, CD diagnoses are increasing with current 
worldwide prevalence at 1% (3). Gluten, the primary 
component of wheat, rye and barley, is the environ-
mental agent responsible for CD. Gluten is difficult to 
digest because it is rich in proline amino acid residues 
that tend to be more resistant to gastric and pancreatic 
enzymatic action. When these long undigested protein 
fragments undergo deamidation by tissue transgluta-
minases they become potent immunogenic epitopes. In 
celiac patients, these gluten-derived peptides bind to 
Major Histocompatibility Complex [MHC, or Human 
Leukocyte Antigen (HLA)] Class II molecules eliciting 
immune stimulation of CD4 T-cells(1).
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ABSTRACT - Background - Celiac disease is an autoimmune enteropathy triggered by the ingestion of gluten in genetically susceptible 
individuals. Genetic susceptibility is associated with two sets of alleles, DQA1*05 - DQB1*02 and DQA1*03 - DQB1*03:02, which 
code for class II MHC DQ2 and DQ8 molecules, respectively. Approximately 90%-95% of celiac patients are HLA-DQ2 positive, 
and half  of the remaining patients are HLA-DQ8 positive. In fact, during a celiac disease diagnostic workup, the absence of these 
specific DQA and DQB alleles has a near perfect negative predictive value. Objective - Improve the detection of celiac disease pre-
disposing alleles by combining the simplicity and sensitivity of real-time PCR (qPCR) and melting curve analysis with the specificity 
of sequence-specific primers (SSP). Methods - Amplifications of sequence-specific primers for DQA1*05 (DQ2), DQB1*02 (DQ2), 
and DQA1*03 (DQ8) were performed by the real time PCR method to determine the presence of each allele in independent reac-
tions. Primers for Human Growth Hormone were used as an internal control. A parallel PCR-SSP protocol was used as a reference 
method to validate our results. Results - Both techniques yielded equal results. From a total of 329 samples the presence of HLA 
predisposing alleles was determined in 187 (56.8%). One hundred fourteen samples (61%) were positive for a single allele, 68 (36.3%) 
for two alleles, and only 5 (2.7%) for three alleles. Conclusion - Results obtained by qPCR technique were highly reliable with no 
discordant results when compared with those obtained using PCR-SSP. 
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Approximately 60% of the genetic susceptibility to 
CD is shared by an unknown number of non-HLA 
genes with each gene estimated to contribute only 
a small proportion to the total risk effect(10); there-
fore, detection of a single non-HLA gene has a low 
positive gain in the diagnosis of  CD. However, two 
sets of alleles, DQA1*05 - DQB1*02 and DQA1*03 
- DQB1*03:02, which code for class II MHC DQ2 
and DQ8 molecules, respectively, are carried by ap-
proximately one-third of the general population and 
account for 40% of the genetic susceptibility to CD(6, 9). 
In fact, approximately 90%-95% of celiac patients are 
HLA-DQ2 positive, while half  of the remaining pa-
tients are HLA-DQ8 positive(4, 5). In addition, during 
a CD diagnostic workup, the absence of these specific 
DQA and DQB alleles has a near perfect negative 
predictive value(10).
Being able to quickly and efficiently determine 
DOI: 10.1590/S0004-28032015000200013
Selleski N, Almeida LM, Almeida FC, Gandolfi L, Pratesi R, Nóbrega YKM. Simplifying celiac disease predisposing HLA-DQ alleles determination by the real time PCR method
144 Arq Gastroenterol v. 52 no. 2 - abr./jun. 2015
the status of these DQA and DQB alleles in potential CD 
patients or risk populations (celiac disease patient’s first 
degree relatives, people with related autoimmune diseases, 
among others) could dramatically aide in diagnostic work-
ups. However, currently available methods for screening 
of  HLA-associated alleles in CD patients, which include 
Sequence-Specific Oligonucleotide Probe Hybridization 
(SSOPH), PCR amplification with Sequence-Specific Primers 
(PCR-SSP), and Sequence-Base Typing (SBT), are expensive 
and time-consuming. The aim of  this study is to simplify 
the detection of three of these alleles (DQA1*03; DQA1*05; 
DQB1*02) by developing a real-time PCR (or quantitative 
PCR, qPCR) protocol with melting curve analysis using 
Sequence-Specific Primers (SSP) previously developed for 
PCR-SSP(7).
METHODS
The study complied with the principles of the latest Dec-
laration of Helsinki (2008) and was approved by the Research 
Ethics Committee on Medical Sciences of the University of 
Brasilia, School of Medicine (protocol nº 132/2008).
DNA was extracted from newborn umbilical cord 
blood (UCB) collected immediately after birth into an 
EDTA-coated tube. All mothers had previously agreed to 
participate in the research. DNA extraction was performed 
using IllustraTM Blood genomic Prep Mini Spin kit (Health-
care, Buckinghamshire, UK) according to the manufac-
turer’s instructions. Concentration of  DNA samples were 
adjusted to 15 ng/µL after being quantified at Nanodrop 
ND-1000 Spectrophotometer (Nanodrop Technologies, 
Wilmington, DE, USA), which measures absorbance at 
260 nm and 280 nm. Samples were considered suitable for 
analyses when the ratio of  absorbances (A260/A280) was 
between 1.8 and 2. 
Sequence-specific primers for DQA1*05 [(5’-ACGGTC-
CCTCTGGCCAGTA, 3’-AGTTGGAGCGTTTAAT-
CAGAC) (DQ2)], DQB1*02 [(5’-GTGCGTCTTGTGAG-
CAGAAG, 3’-GCAAGGTCGTGCGGAGCT) (DQ2)], 
and DQA1*03 [(5’-TTCACTCGTCAGCTGACCAT, 
3’-CAAATTGCGGGTCAAATCTTCT) (DQ8)] previ-
ously described by Olerup et al. (1993)(7) were used to test 
for the presence of  each allele in independent reactions. 
Primers for Human Growth Hormone (HGH) were used as 
an internal control(8). Amplifications were performed on a 
StepOne Real-Time PCR System (Applied Biosystems-Life 
Technologies™, Carlsbad, CA, USA). For DQ alleles, 
amplifications were performed in 20 µL volume containing 
2 µL of genomic DNA, 0.5 µM DQ-forward primer, 0.5 µM 
DQ-reverse primer, and 1X Thermo Scientific Absolute-
QPCR SYBR Green ROX Mix (Thermo Fisher Scientific 
Inc., Vilnius, Lithuania). For HGH control samples re-
actions were performed in 20µL volume containing 2 µL 
of  genomic DNA, 0.5 µM HGH-specific forward primer, 
0.5 µM HGH-specific reverse primer, and 1X Thermo Scien-
tific Absolute QPCR SYBR Green ROX Mix (Thermo Fisher 
Scientific Inc., Vilnius, Lithuania). A positive control or 
reference sample (DNA sample known to be positive for the 
searched alleles) was included in all reactions to standardize 
interpretations. Additionally, a known negative DNA sample 
(not containing the region of interest) and negative control 
(no DNA added to reaction) were run in set of reactions to 
test for contamination. PCR and melting curve conditions 
are detailed in Table 1. Amplified products were analyzed 
using a melting curve.
Since this was the first attempt to use this protocol with 
these alleles, we used a parallel PCR-SSP protocol as a refer-
ence method to validate our positive results. The conditions 
and reactions were performed using DQ-CD Typing Kit Plus 
(BioDiagene, Palermo, Italy) according to the manufacturer’s 
recommendations.
RESULTS
Results obtained by qPCR technique were determined to 
be highly reliable with no discordant results when compared 
with those obtained using PCR-SSP; however, the latter 
technique did provide some additional details in terms of 
homozygosity and heterozygosity, which will be detailed 
shortly. Using both techniques, from a total of 329 samples, 
187 (56.8%) were determined positive for HLA predisposing 
alleles. With qPCR, these 187 positive samples could be sub-
divided into 114 (61.0%) positive for a single allele, 68 (36.3%) 
for two alleles, and only 5 (2.7%) for three alleles (Table 2). 
The evidenced mean Tm for the three analyzed alleles were 
80.12 ± 0.1ºC for DQA1*05; 86.49 ± 0.13ºC for DQB1*02 
and 80.69 ± 0.11ºC for DQA1*03, melting curves for each are 
TABLE 1. qPCR conditions including temperature, time, and number 
of cycles, for DQA1*05, DQB1*02, DQA1*03 alleles and HGH gene
Step Temperature (ºC) Time Cycles
Initial denaturation 95 10 min. 1
Denaturation 95 15 sec.
32
Annealing and extension 60 60 sec.
Melt curve - step 1 95 15 sec.
1Melt curve - step 2 60 60 sec.
Melt curve - step 3 60-95* -
* Temperature increases from 60ºC to 95ºC by increments of 0.3ºC with simultaneous SYBR 
Green I signal monitoring.
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shown in Figure 1. For the HGH gene, the evidenced mean 
Tm was 83.5ºC ± 0.1ºC. The most common combination of 
positive alleles was DQA1*05 and DQB1*02 (Table 2), which 
code for class II MHC DQ2 molecules. With PCR-SSP, these 
187 could be further subdivided to inform whether a sample 
was heterozygous (DQB1*02/x; n=70; 37.5%) or homozygous 
(DQB1*02/02 haplotype; n=22; 11.7%) for the β-chain of 
the DQ2 which allowed to differentiate between haplotypes 
in cis and trans (Table 2).
DISCUSSION
In light of  the great need of  cost-effective and specific 
assays for the determination of celiac associated HLA alleles 
(especially in high-risk populations), we successfully devel-
oped a qPCR technique that uses PCR-SSP primers. As we 
chose to use primers that were originally designed to be used 
with PCR-SSP method(7), all qPCR results were confirmed 
using a reference method (DQ-CD TypingKitPlus). The qP-
CR-based typing system, despite its incapability to determine 
DQB1*02 allele homozygosis, proved to be highly reliable 
with no discordant results compared with the ones obtained 
with PCR-SSP. Determination of DQB1*02 homozygosis, 
although important when estimation of risk of having celiac 
disease is pursued, has a low relevance when the goal is to 
identify, inside a high risk population, which patients must 
be followed up, as was intended in this work. 
Considering that qPCR procedures are faster, comprise 
fewer handling steps and are highly sensitive; we can affirm 
that this study managed to combine the simplicity of  re-
al-time PCR with the specificity of PCR-SSP. This makes it 
an excellent candidate when it comes to clinics, both in the 
detection of the genetic bases of the disease in a patient, for 
later familiar screenings to detect predisposition of developing 
the disease, and in the main role of HLA typing that lies in its 
high negative predictive value to exclude CD (close to 100%) (10). 
Moreover, the fact of being a simple laboratory technique with 
few requirements, both in handling steps and equipments, 
can sometimes make the difference between finishing or not a 
scientific work for some scientist of developing countries who, 
like us, do not always have access to imported commercial 
kits or even having, the delay in arriving could interfere in 
the development of our work. One of the limitations of this 
study was not having analyzed the DQB1*03:02 allele, which 
is also associated with celiac disease. The reason for that was 
that the par of primers cited by Olerup et al. (1993), for this 
allele, also amplified DQB1*03:03 which is not related to celiac 
TABLE 2. Summary of the 187 samples that tested positive, with PCR-
-SSP and qPCR, for one or more of three analyzed HLA predisposing 
alleles: DQA1*05 (DQ2), DQB1*02 (DQ2), and DQA1*03 (DQ8). The 
number of individuals (and % of total) determined to be positive at one 



















DQA1*03 37 (19.8) 37 (19.8)§
DQA1*03
DQB1*02 10 (5.3) 10 (5.3)
#
Total 187 (56.8) 187 (56.8)
DQB1*02/02: homozygosity of the β-chain of the DQ2; DQB1*02/x: heterozygosity of the 
β-chain of the DQ2; ‡Samples that were heterozygous for DQB1*02 (∑ 70); ♠Samples that 
were homozygous for DQB1*02 (∑ 22). §Samples that tested positive for only one allele (∑ 
114); #Samples that tested positive for two alleles (∑ 68).
FIGURE 1. Melting curves of the analyzed alleles. A: DQA1*05; B: DQB1*02; C: DQA1*03
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RESUMO - Contexto - Doença celíaca é uma enteropatia autoimmune desencadeada pela ingestão de gluten em indivíduos geneticamente suscetíveis. Essa 
suscetibilidade genética está associada a dois conjuntos de alelos, DQA1*05 - DQB1*02 e DQA1*03 - DQB1*03:02, que codificam moléculas MHC 
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Objetivo - Nosso objetivo foi melhorar a detecção de alguns alelos predisponentes para doença celíaca, combinando a simplicidade e sensibilidade 
da técnica de PCR em tempo real (qPCR) e análise da curva de melting com a especificidade dos primers de sequência específica. Métodos - Primers 
de sequência específica para DQA1*05 (DQ2), DQB1*02 (DQ2), e DQA1*03 (DQ8) foram usados para testar a presença de cada alelo em reações 
independentes. Primers para Hormônio de Crescimento Humano foram usados como controle interno. Em paralelo, foi usado um protocolo de PCR-
SSP como um método de referência para validar nossos resultados positivos. Resultados - Das 329 amostras testadas, 187 (56.8%) foram positivas 
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um alelo, 68 (36.3%) para dois alelos e apenas 5 (2.7%) para os três alelos. Conclusão - Os resultados obtidos pela técnica de qPCR mostraram-se 
altamente confiáveis, sem resultados discordantes quando comparados àqueles obtidos pelo método PCR-SSP.
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